# FDA Inspection 1009741 - Fisher BioServices - April 21, 2017

Source: https://www.keypedia.com/records/fda_inspections/fisher-bioservices/d7d5c5b5-8475-41fa-8c0a-4df6628f41ba
Source feed: FDA_Inspections

> FDA Inspection 1009741 for Fisher BioServices on April 21, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1009741
- Company Name: Fisher BioServices
- Inspection Date: 2017-04-21
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 777716 - 2012-04-20](https://www.keypedia.com/records/fda_inspections/fisher-bioservices/f8795bd4-7c4a-4ece-85ec-e2a3d5a0de80)
- [FDA Inspection 648588 - 2010-01-07](https://www.keypedia.com/records/fda_inspections/fisher-bioservices/b12b120b-03ac-4232-a73d-5932e0a4063d)

Company: https://www.keypedia.com/companies/fisher-bioservices/c69c4ab9-8abb-458f-9524-d980d099463d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d